Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

Co-led by return investor Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will support Vitestro’s commercialization in Europe and its organizational expansion into the U.S. market.

Continue ReadingVitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device